So an upfront payment of $35 mil, $50 mil, $75 mil by a Pharma Co. WOULD NOT be considered revenue?

"Our initial target market for LymPro will be the pharmaceutical industry, for enrichment of their clinical trial enrollment population prior to undergoing the expense and waste of advanced imaging techniques for Alzheimer's biomarkers for beta amyloid and tau," said Dr. Louis Kirby

We are well positioned to continue forward with our LymPro program and remain on track to achieve our corporate objectives by the end of 2014